Hiranandani slams Trump’s 100% pharma tariff, calls for GST cut to unlock ₹25,000 crore boost for Indian economy
Real estate tycoon and policy commentator Niranjan Hiranandani has sharply criticized US President Donald Trump’s recent decision to impose a 100% tariff on Indian pharmaceutical exports, calling it “counterproductive and protectionist.” In a statement issued on September 26, 2025, Hiranandani warned that the move could disrupt global healthcare supply chains and hurt both Indian manufacturers…